Perceptions of benefit noted in study. por Cassandra P. Griffin (17684463)

Subjects:

Included studies. por Cassandra P. Griffin (17684463)

Subjects:

Items included. por Beatriz Goulão (16498275)

“...Four items reached consensus regarding critical importance for patient and public involvement: presentation of results to trial participants; summary and presentation of harms; interpretation and presentation of findings in an academic setting; factors impacting how well a treatment works. ...”

Flow of participants in the Delphi survey. por Beatriz Goulão (16498275)

“...Four items reached consensus regarding critical importance for patient and public involvement: presentation of results to trial participants; summary and presentation of harms; interpretation and presentation of findings in an academic setting; factors impacting how well a treatment works. ...”

S1 Data - por John Twomey (12595255)

Subjects:

Prevalence of tweets over time in the dataset. por John Twomey (12595255)

Subjects:

Timeline of the use of deepfakes/synthetic media in the war. por John Twomey (12595255)

Subjects:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects:

Mean total number of benzodiazepine prescriptions administered by top prescribers at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects:

Mean rate (per 100) of new-start benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention–sensitivity analysis. por Meagan Lacroix (16698830)

Subjects:

Baseline characteristics of physicians and patients–prescribers in top 25 percent. por Meagan Lacroix (16698830)

Subjects:

Mean total number of benzodiazepine prescriptions administered by top prescribers at 12 months pre- to 18 months post-intervention–sensitivity analysis. por Meagan Lacroix (16698830)

Subjects:

Mean rate (per 100) of high-risk benzodiazepine prescriptions administered to patients >65 at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects:

Mean total number of benzodiazepine prescriptions administered at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects:

Mean rate (per 100) of high-risk benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects:

Mean total number of benzodiazepine prescriptions administered at 12 months pre- to 18 months post-intervention for patients > 65. por Meagan Lacroix (16698830)

Subjects:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention–sensitivity analysis. por Meagan Lacroix (16698830)

Subjects:

Mean rate (per 100) of new-start benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects:

Estimates of percent change in slope of total benzodiazepine prescriptions after the intervention vs before. por Meagan Lacroix (16698830)

Subjects:

Mean rate (per 100) of high-risk benzodiazepine prescriptions at 12 months pre- to 18 months post-intervention. por Meagan Lacroix (16698830)

Subjects: